Synergy Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies to treat gastrointestinal diseases and disorders. The company has market cap of $468.65 million. The Company’s lead product is plecanatide, a novel uroguanylin analog that is traded under the TRULANCE name for the treatment of chronic idiopathic constipation and irritable bowel syndrome. It currently has negative earnings. The firm also develops dolcanatide to treat mild-to-moderate ulcerative colitis.
Proshare Advisors Llc decreased C H Robinson Worldwide Inc (CHRW) stake by 68.94% reported in 2017Q3 SEC filing. Proshare Advisors Llc sold 29,345 shares as C H Robinson Worldwide Inc (CHRW)’s stock declined 14.80%. The Proshare Advisors Llc holds 13,223 shares with $1.01 million value, down from 42,568 last quarter. C H Robinson Worldwide Inc now has $12.94B valuation. The stock increased 2.82% or $2.54 during the last trading session, reaching $92.63. About 1.00M shares traded. C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW) has declined 7.85% since February 24, 2017 and is downtrending. It has underperformed by 24.55% the S&P500.
Analysts await C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW) to report earnings on April, 24. They expect $0.99 EPS, up 15.12% or $0.13 from last year’s $0.86 per share. CHRW’s profit will be $138.33 million for 23.39 P/E if the $0.99 EPS becomes a reality. After $0.99 actual EPS reported by C.H. Robinson Worldwide, Inc. for the previous quarter, Wall Street now forecasts 0.00% EPS growth.
Investors sentiment decreased to 1.01 in Q3 2017. Its down 0.23, from 1.24 in 2017Q2. It is negative, as 57 investors sold CHRW shares while 128 reduced holdings. 37 funds opened positions while 150 raised stakes. 129.16 million shares or 3.64% more from 124.62 million shares in 2017Q2 were reported. Fort Washington Advsrs Inc Oh invested in 18,524 shares or 0.02% of the stock. Cwm Ltd Liability holds 443,397 shares or 1.6% of its portfolio. State Board Of Administration Of Florida Retirement Sys reported 0.05% of its portfolio in C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW). Fifth Third Financial Bank reported 2,304 shares stake. Baldwin Invest Limited Liability holds 7,150 shares. 75,321 are held by Investec Asset Mgmt Ltd. Moreover, Voya Inv Lc has 0.02% invested in C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW) for 97,997 shares. Corp Va stated it has 1.76% of its portfolio in C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW). Cornerstone Capital Management Hldg Limited Co reported 0.01% in C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW). Parnassus Investments Ca reported 430,000 shares. Moreover, Dupont Cap Corporation has 0.01% invested in C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW). Rodgers Brothers owns 7,800 shares. Sun Life, Ontario – Canada-based fund reported 1,032 shares. Pub Employees Retirement Association Of Colorado holds 26,290 shares. Tocqueville Asset Mngmt Lp, New York-based fund reported 8,500 shares.
Proshare Advisors Llc increased Capital One Finl Corp (NYSE:COF) stake by 15,629 shares to 124,523 valued at $10.54M in 2017Q3. It also upped Occidental Pete Corp Del (NYSE:OXY) stake by 30,676 shares and now owns 157,258 shares. Universal Corp Va (NYSE:UVV) was raised too.
Among 23 analysts covering C.H. Robinson Worldwide (NASDAQ:CHRW), 9 have Buy rating, 2 Sell and 12 Hold. Therefore 39% are positive. C.H. Robinson Worldwide had 86 analyst reports since July 30, 2015 according to SRatingsIntel. Stifel Nicolaus maintained C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW) on Thursday, October 5 with “Hold” rating. The firm has “Underweight” rating given on Friday, February 2 by Morgan Stanley. On Thursday, September 14 the stock rating was maintained by Robert W. Baird with “Hold”. The rating was maintained by Stifel Nicolaus on Monday, September 11 with “Hold”. Stifel Nicolaus maintained the stock with “Buy” rating in Wednesday, October 26 report. As per Wednesday, July 29, the company rating was maintained by Cowen & Co. The company was upgraded on Tuesday, September 5 by UBS. BMO Capital Markets maintained C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW) rating on Wednesday, January 31. BMO Capital Markets has “Hold” rating and $96.0 target. As per Thursday, November 2, the company rating was maintained by Cowen & Co. The firm earned “Hold” rating on Thursday, July 20 by BMO Capital Markets.
Since February 12, 2018, it had 0 insider purchases, and 3 selling transactions for $913,481 activity. 4,346 C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW) shares with value of $403,092 were sold by LEMKE JAMES. OBRIEN CHRIS had sold 3,909 shares worth $355,113. On Tuesday, February 13 the insider Kass Jordan T sold $155,276.
Analysts await Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) to report earnings on March, 1 after the close. They expect $-0.19 earnings per share, up 38.71% or $0.12 from last year’s $-0.31 per share. After $-0.22 actual earnings per share reported by Synergy Pharmaceuticals Inc. for the previous quarter, Wall Street now forecasts -13.64% EPS growth.
Great Point Partners Llc holds 1.85% of its portfolio in Synergy Pharmaceuticals Inc. for 3.27 million shares. Trellus Management Company Llc owns 362,500 shares or 1.44% of their US portfolio. Moreover, Cheyne Capital Management (Uk) Llp has 0.68% invested in the company for 1.63 million shares. The Japan-based Hikari Power Ltd has invested 0.56% in the stock. Orbimed Advisors Llc, a New York-based fund reported 13.62 million shares.